Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes
Authors:
- Stefan KopfSKStefan Kopf
- Zdenka DjuricZDZdenka Djuric
- Thoralf WendtTWThoralf Wendt
- Michael MorcosMMMichael Morcos
- Peter P. NawrothPNPeter P. Nawroth
- Angelika BierhausABAngelika Bierhaus
Open Access
- 1 May 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (5) , 1111-1113
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Increased Serum Concentrations of Soluble Receptor for Advanced Glycation Endproducts in Patients with Type 1 DiabetesClinical Chemistry, 2005
- Long-Term Renal Effects of a Neutralizing RAGE Antibody in Obese Type 2 Diabetic MiceDiabetes, 2004
- RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic NephropathyThe American Journal of Pathology, 2003
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null MiceCirculation, 2002
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal DiseaseJournal of the American Society of Nephrology, 2000
- Expression of receptors for advanced glycosylated end-products in renal diseaseNephrology Dialysis Transplantation, 1995
- Accurate Estimation of Glomerular Filtration Rate in Diabetic Nephropathy From Age, Body Weight, and Serum CreatinineDiabetes Care, 1992